[Effects of trimepranol and propranolol in thyreotoxicosis and in patients with arrhythmia].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D000605:Amino Alcohols / Q000494:pharmacology / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D006329:Heart Conduction System / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use*; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D011437:Propylamines; D013565:Sympatholytics; D011433:Propranolol
Nĕkteré úcinky trimepranolu a propranololu u nemocných tyreotoxikózou a nemocných s nĕkterými arytmiemi srdecními.